Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Alpha has not published a narrative summary because the current public source set is not sufficient.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Director

DSS, INC. (NYSE: DSS)

Jan 1, 2020 – Present

Independence: Not stated

Source effective: 2025-10-20 · Observed: 2026-09-02T00:26:01.1259+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Connections

Explore the roles, education and affiliations published in this record.

DSS, INC.

Open DSS, INC. profile →

Director at DSS, INC.

2020-01-01 → End not stated

current · source reported

Observed: 2026-09-13

Chief Financial Officer at DSS, INC.

Start not stated → End not stated

current · source reported

Observed: 2026-09-13

DSS, INC.DSS, INC.IMPACT BIOMEDICAL …IMPACT BIOMEDICAL INC.Todd D. Macko

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingDSS 10-K executive officersSupports Executive company, Executive title.Open sourceSource 2 · Sec FilingIBO 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 3 · Sec ProxyPublic profile sourceSupports Director at DSS, INC. (NYSE: DSS), Board membership.Open sourceSource 4 · Sec Def 14aPublic profile sourceSupports Chief Financial Officer at IMPACT BIOMEDICAL INC. (NYSE: IBO).Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:todd-d-macko
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of DSS, INC.1 source
Verification
Source reported
Confidence
88%
Last reviewed
Sep 6, 2026
Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at DSS, INC.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at IMPACT BIOMEDICAL INC.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · CorroboratedExecutive title: Chief Financial OfficerSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources5 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  3. https://www.sec.gov/Archives/edgar/data/771999/000149315225018592/formdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Sep 2, 2026

    Supports: Director at DSS, INC. (NYSE: DSS) · Board membership

  4. https://www.sec.gov/Archives/edgar/data/771999/000149315225018592/formdef14a.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 6, 2026

    Supports: Chief Financial Officer at DSS, INC. (NYSE: DSS)

  5. https://www.sec.gov/Archives/edgar/data/1834105/000149315225014484/formdef14a.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 6, 2026

    Supports: Chief Financial Officer at IMPACT BIOMEDICAL INC. (NYSE: IBO)